UBS Group’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.7M Hold
860,880
0.01% 1566
2026
Q1
$59.3M Hold
860,880
0.01% 1471
2025
Q4
$75.9M Hold
860,880
0.01% 1239
2025
Q3
$71.7M Hold
860,880
0.01% 1295
2025
Q2
$80.5M Hold
860,880
0.01% 1127
2025
Q1
$91M Hold
860,880
0.02% 990
2024
Q4
$83.3M Hold
860,880
0.02% 1035
2024
Q3
$85.1M Hold
860,880
0.02% 815
2024
Q2
$74M Hold
860,880
0.02% 802
2024
Q1
$65.2M Buy
+860,880
New +$66.5M 0.02% 876

Other funds holding MMSI

UBS Group's MMSI Position: Q2 2026 in Review

UBS Group increased its Merit Medical Systems (MMSI) stake by 45% in Q2 2026, buying an estimated $10.2M and bringing the position to 495,598 shares worth $34.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

UBS Group first reported a position in MMSI in Q4 2014 and has held it in 47 quarters since. The position peaked at $79.6M in Q1 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • UBS Group held 495,598 shares of Merit Medical Systems worth $34.4M as of Q2 2026.
  • UBS Group bought 154,972 Merit Medical Systems shares in Q2 2026, an estimated $10.2M.
  • Merit Medical Systems made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2118 holding.
  • UBS Group first reported a position in Merit Medical Systems in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Merit Medical Systems position peaked at $79.6M in Q1 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.